METTL3 and colorectal carcinoma: For example, METTL3 induced m6A-modified CBX8 promotes expression of LGR5, a well-established marker of gastric and colorectal cancer stem cells, through recruiting Pol II and KMT2b transcriptional complexes to maintain stemness of CRC CSCs and promoting drug resistance [111].